12.3 Community Programs, Documentation & Care Coordination Across Settings

12.3 Community Programs, Documentation & Care Coordination Across Settings

Clinical Pearl: The closing of a diabetic foot ulcer does not mark the conclusion of treatment; it marks the entry of the patient into lifelong remission. Because up to 40% of diabetic ulcers recur within 12 months and 65% recur within 5 years, care coordination must be continuous, structured, and proactive. The foot care nurse is the central architect who binds hospital limb salvage, home health, community programs, and outpatient protective surveillance into a cohesive continuum.

---

Care Continuity Across Transitions & Clinical Settings

Patients navigating lower extremity limb salvage transition through multiple distinct healthcare environments. A single patient journey frequently spans the acute inpatient hospital (for surgical revascularization, fasciotomy, or partial amputation), an inpatient rehabilitation facility (IRF) or skilled nursing facility (SNF) (for functional recovery and parenteral antibiotic completion), home health nursing (for dressing changes and home safety assessments), and outpatient specialized clinics (podiatry, vascular, wound care centers, and nurse-led foot care clinics).

Communication breakdowns during these care transitions represent the leading cause of preventable readmissions, treatment failures, and recurrent amputations. To ensure uninterrupted safety, foot care nurses utilize structured interprofessional handoff tools, most notably the SBAR Framework (Situation, Background, Assessment, Recommendation) adapted specifically for lower extremity care:

+-------------------------------------------------------------------------+
|                   TAILORED SBAR FOOT CARE HANDOFF TOOL                  |
+-------------------------------------------------------------------------+
| [S] SITUATION:                                                          |
| - Patient identification, setting, immediate reason for escalation.    |
| - Example: "This is Nurse Davis calling from Home Health regarding      |
|   Mr. John Doe (DOB 04/12/1954). He has an acutely expanding, painful   |
|   plantar 1st metatarsal ulcer with advancing periwound erythema."     |
+-------------------------------------------------------------------------+
| [B] BACKGROUND:                                                         |
| - Underlying systemic pathologies, baseline vascular status, history.   |
| - Example: "Mr. Doe has Type 2 diabetes (HbA1c 9.2%), dense peripheral  |
|   neuropathy, and known PAD with a resting ABI of 0.55. He completed a  |
|   left 2nd ray amputation 8 months ago. Currently taking oral keflex." |
+-------------------------------------------------------------------------+
| [A] ASSESSMENT:                                                         |
| - Objective clinical findings: dimensions, tissue, drainage, pulses.    |
| - Example: "Ulcer measures 2.2 x 1.8 x 0.4 cm with 50% slough. Periwound|
|   erythema has expanded 3.5 cm proximally over 24 hours. Drainage is     |
|   copious and purulent with a foul odor. Positive probe-to-bone at the  |
|   base. Pedal pulses are non-palpable. Vitals: T 38.4°C, HR 108, BP 98/62."|
+-------------------------------------------------------------------------+
| [R] RECOMMENDATION:                                                     |
| - Concrete, actionable request for intervention or specialist review.   |
| - Example: "I recommend urgent transfer to the Emergency Department for |
|   podiatric surgical debridement, blood cultures, parenteral broad-     |
|   spectrum antibiotics, and inpatient vascular surgery consultation." |
+-------------------------------------------------------------------------+

---

Accessing and Navigating Community Disease Prevention Programs

Long-term limb preservation requires leveraging accredited community-based resources to address underlying behavioral, socio-economic, and metabolic risk factors.

1. Diabetes Self-Management Education and Support (DSMES)

DSMES is an evidence-based, patient-centered service accredited by the Association of Diabetes Care & Education Specialists (ADCES) or the American Diabetes Association (ADA).

• Clinical Impact: Participation in DSMES produces sustained reductions in HbA1c of 0.5% to 1.0%, lowers all-cause mortality, improves medication adherence, and significantly reduces acute hospitalizations.
• Core Curricular Focus for Foot Health: Instruction on daily self-foot examinations (using telescoping inspection mirrors or caregiver assistance), proper skin hydration (avoiding interdigital spaces), safe bathwater temperature testing (using elbow or bath thermometer to prevent scald burns), prompt recognition of pre-ulcerative lesions (calluses, blisters, ingrown nail spikes), and safe footwear habits.
• Medicare Coverage: Medicare Part B covers 10 hours of initial DSMES education within the first 12 months of diagnosis (including 1 hour of individual assessment and 9 hours of group training), followed by 2 hours of annual maintenance education each subsequent calendar year with a physician's referral.

2. The Medicare Therapeutic Shoe Program

Codified under the Social Security Act (§1861(s)(12)), the Medicare Therapeutic Shoe Program (also known as the Diabetic Shoe Benefit) provides annual coverage for specialized protective footwear and custom inserts for individuals with diabetes who demonstrate qualifying high-risk foot conditions.

Qualifying High-Risk Foot Criteria (Must have Diabetes PLUS at least ONE):

1. History of partial or complete foot amputation (e.g., ray resection, transmetatarsal amputation).
2. History of previous foot ulceration.
3. History of pre-ulcerative callus formation.
4. Peripheral neuropathy with evidence of callus formation.
5. Significant structural foot deformity (e.g., severe hallux valgus, hammer toes, Charcot rocker-bottom foot).
6. Poor peripheral circulation (documented peripheral arterial disease, claudication, or diminished pedal pulses).

The Administrative Tripartite Execution Process:

• Certifying Physician (MD or DO): Must be the medical doctor or osteopathic physician actively managing the patient's comprehensive systemic diabetes. The certifying physician conducts a face-to-face diabetic foot evaluation within 6 months of the footwear order and signs the official Statement of Certifying Physician (SCP) affirming that the patient has diabetes, exhibits at least one qualifying condition, and requires therapeutic footwear. Podiatrists, nurse practitioners, and physician assistants cannot legally sign as the certifying physician unless acting as the designated primary provider under strict state-specific supervising regulations; Medicare requires an MD or DO signature.
• Prescribing Practitioner: A podiatrist (DPM) or physician (MD/DO) who conducts a comprehensive biomechanical exam and writes the detailed written prescription for the specific shoe and insert types.
• Dispensing Supplier: A Certified Pedorthist (C.Ped), Certified Orthotist (CO), prosthetist, or qualified podiatrist who measures the feet, casts/scans for custom inserts, fabricates or orders the footwear, fits the footwear on the patient, and performs an in-person evaluation of the fit prior to final dispensing.

Annual Covered Footwear Allowances (Per Calendar Year):

• Option A: One pair of custom-molded shoes (HCPCS code A5501) and three pairs of multi-density custom inserts (A5513/A5514); OR
• Option B: One pair of extra-depth shoes (HCPCS code A5500) and three pairs of multi-density custom inserts (A5513/A5514) or prefabricated heat-moldable inserts (A5512).

3. Community Smoking Cessation Programs & State Quitlines

Cigarette smoking is an exceptionally virulent risk factor for lower extremity amputation in patients with diabetes and PAD:

• Pathophysiology: Nicotine induces acute vasoconstriction and reduces digital microvascular flow by up to 40% for 60 minutes after a single cigarette. Carbon monoxide binds hemoglobin to form carboxyhemoglobin, shifting the oxygen-hemoglobin dissociation curve to the left and starving healing tissue of oxygen. Smoking accelerates arterial intimal hyperplasia, calcification, and in-situ thrombosis, increasing the risk of major amputation up to 3-fold.
• Referral Execution: Foot care nurses should utilize the "5 A's" Framework (Ask, Advise, Assess, Assist, Arrange). Refer patients directly to state tobacco quitlines (1-800-QUIT-NOW), hospital-based cessation clinics, and collaborate with primary providers to initiate combination Nicotine Replacement Therapy (NRT) or oral varenicline/bupropion.

---

Long-Term Outcome Surveillance & IWGDF Risk-Based Follow-Up Intervals

Diabetic foot ulceration is not an acute, self-limiting event; it is a chronic, relapsing disease. Modern limb preservation guidelines emphasize the concept of the "Diabetic Foot in Remission" (Armstrong & Mills). Epidemiological studies show that following complete wound closure:

• 40% of ulcers recur within 1 year.
• 60% to 65% of ulcers recur within 3 to 5 years.
• The 5-year mortality rate following a major diabetic lower extremity amputation exceeds 50%, a mortality rate higher than colon cancer, breast cancer, and prostate cancer.

To prevent catastrophic recurrence, the International Working Group on the Diabetic Foot (IWGDF) established an evidence-based risk stratification system that dictates the frequency of professional surveillance:

+-------------------------------------------------------------------------+
|       THE CHRONIC FOOT CARE CONTINUITY & SECONDARY PREVENTION CYCLE      |
+-------------------------------------------------------------------------+
|                                                                         |
|          +---------------------------------------------------+          |
|          |         EPITHELIALIZED WOUND / IN REMISSION       |          |
|          +---------------------------------------------------+          |
|                                    |                                    |
|                                    v                                    |
|          +---------------------------------------------------+          |
|          |      IWGDF RISK STRATIFICATION (CATEGORY 0 - 3)   |          |
|          +---------------------------------------------------+          |
|                                    |                                    |
|                   +----------------+----------------+                   |
|                   |                                 |                   |
|                   v                                 v                   |
|       [ CATEGORY 1 & 2 ]                    [ CATEGORY 3 ]              |
|       Exam every 3 to 12 months             Exam every 1 to 3 months    |
|       - Pedorthic custom shoes              - High-frequency debridement|
|       - Routine hyperkeratosis removal      - Dermal thermometry        |
|       - Monofilament surveillance           - Rapid specialist triage   |
|                   \                                 /                   |
|                    +---------------+---------------+                    |
|                                    |                                    |
|                                    v                                    |
|          +---------------------------------------------------+          |
|          |           PREVENTION OF RECURRENT ULCERATION      |          |
|          |          Preserving Mobility, Limb & Life         |          |
|          +---------------------------------------------------+          |
+-------------------------------------------------------------------------+

IWGDF Risk Stratification System & Minimum Follow-Up Schedules

---

Medical-Legal Documentation Standards in Foot Care Nursing

In specialized nursing practice, contemporaneous, defensive, and meticulous documentation is essential to demonstrate clinical standard of care, facilitate interdisciplinary handoffs, and protect against professional liability:

1. Baseline Neurovascular & Dermatologic Assessment:
   • Document objective pedal pulses (palpable 0–4+ or biphasic/triphasic Doppler signals over dorsalis pedis and posterior tibial arteries).
   • Capillary refill time in seconds (<3 seconds normal; >5 seconds abnormal).
   • Loss of Protective Sensation results: document specific anatomical sites tested using the 5.07 / 10-gram Semmes-Weinstein monofilament (standard 10-site test).
   • Dermal temperature recordings, noting presence or absence of unilateral calor.
2. Objective Lesion Documentation:
   • Anatomical location described with surgical precision (e.g., "plantar aspect of left 1st metatarsal head").
   • Precise metric dimensions: length x width x depth in millimeters (not centimeters) using disposable paper rulers.
   • Tissue bed composition expressed in percentages (e.g., 80% healthy red granulation, 20% yellow fibrinous slough, 0% eschar).
   • Exudate: volume (none, scant, small, moderate, copious), type (serous, serosanguinous, purulent), and odor.
   • Undermining and tunneling: measured in millimeters and documented using the face of a clock (with 12:00 oriented toward the patient's head).
3. Calibrated Photo-Documentation:
   • Photographs obtained prior to and immediately following clinical procedures, where institutional policy and patient consent permit.
   • Always include a metric calibration sticker displaying patient identifier, date, time, and nurse's initials in the field of view.
4. Procedural Details & Instrument Tracking:
   • Specific instrumentation used (e.g., sterilized straight-jaw nipper, rotary burs, single-use scalpel #10 or #15 blade).
   • Sterilization lot/autoclave batch numbers recorded in the medical record to establish sterility assurance.
   • Hemostatic agents applied (e.g., pressure, silver nitrate applicator with lot number, calcium alginate).
5. Patient Education, Comprehension & Consent:
   • Document explicit patient instructions provided (e.g., offloading device adherence, keep dressings dry, daily self-inspection).
   • Record verification of comprehension utilizing the "Teach-Back" method (e.g., "Patient demonstrated correct verbalization of red-flag symptoms including spreading redness, foul odor, or fever").
   • Signed informed consent for conservative debridement procedures and formal documentation of any treatment refusals with documented explanations of clinical risks.